Cetuximab Combined With Sonodynamic Therapy Achieves Dual-Modal Image Monitoring for the Treatment of EGFR-Sensitive Non-Small-Cell Lung Cancer

BACKGROUND: Blocking signaling by epidermal growth factor receptor (EGFR), can effectively inhibit the proliferation and differentiation of non-small-cell lung cancer (NSCLC). Additionally, an increasing number of NSCLC patients have treatment limitations caused by EGFR overexpression or mutations....

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Guanhua, Xue, Lianfang, Zhu, Xiaoqi, Lu, Xiuxin, Liu, Lidong, Wang, Zhonghai, Li, Xiangdong, Huang, Cuiqing, Liu, Junjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886674/
https://www.ncbi.nlm.nih.gov/pubmed/35242698
http://dx.doi.org/10.3389/fonc.2022.756489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886674/
https://www.ncbi.nlm.nih.gov/pubmed/35242698
http://dx.doi.org/10.3389/fonc.2022.756489

Ejemplares similares